Matches in Nanopublications for { ?s ?p "[Our findings offer preclinical proof-of-concept for IRS1/2 inhibitors as cancer therapeutics including PLX4032-resistant melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_assertion description "[Our findings offer preclinical proof-of-concept for IRS1/2 inhibitors as cancer therapeutics including PLX4032-resistant melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515464.RATHp-QbsYzi9j3uAwR3KMo7j0tP3LYifLqTmj4ve7tTs130_provenance.
- assertion description "[Our findings offer preclinical proof-of-concept for IRS1/2 inhibitors as cancer therapeutics including PLX4032-resistant melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP515604.RAhoGD5xVm7o8fVGdLgfOEygQNSI5Fvup6G8VqLmolJ9s130_assertion description "[Our findings offer preclinical proof-of-concept for IRS1/2 inhibitors as cancer therapeutics including PLX4032-resistant melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515604.RAhoGD5xVm7o8fVGdLgfOEygQNSI5Fvup6G8VqLmolJ9s130_provenance.
- NP1075732.RAYaGBn4rBx6HR0TuKi58N6WkqLmegFk5CmxHxXLfmjE8130_assertion description "[Our findings offer preclinical proof-of-concept for IRS1/2 inhibitors as cancer therapeutics including PLX4032-resistant melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1075732.RAYaGBn4rBx6HR0TuKi58N6WkqLmegFk5CmxHxXLfmjE8130_provenance.
- NP797851.RAIukbELze3ZcsLxaJCurCFNa_vDdJGPcjlQNAERG9OeE130_assertion description "[Our findings offer preclinical proof-of-concept for IRS1/2 inhibitors as cancer therapeutics including PLX4032-resistant melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797851.RAIukbELze3ZcsLxaJCurCFNa_vDdJGPcjlQNAERG9OeE130_provenance.
- NP515369.RAHKOq16uz_INEY866WmEhCINjq0QFdlw3w4TRoLzFvtE130_assertion description "[Our findings offer preclinical proof-of-concept for IRS1/2 inhibitors as cancer therapeutics including PLX4032-resistant melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515369.RAHKOq16uz_INEY866WmEhCINjq0QFdlw3w4TRoLzFvtE130_provenance.